Your Cart

ISO 13485 & ISO 9001 Certificates

Apostle Inc is pleased to receive the Certificates of Conformance to certify that Quality Management System of Apostle Inc. has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by: ISO13485:2016, and ISO9001:2015. The Quality Management System is applicable to DEVELOPMENT, MANUFACTURING, LICENSING AND SALES OF CONSUMABLES AND CHEMICALS FOR NUCLEIC ACID RESEARCH.

Click the images below to access the certificates.


Nature Communications just published a clinical study, including 2125 cancer patients, 9 cancer types, using the Apostle Minimax cfDNA technology. This study demonstrates the ability of its model to detect early-stage cancers using cfDNA, including those of pancreatic origin, with high sensitivity that is comparable to that of late-stage detection. Congratulations to this clinical research team. To date, the Apostle Minimax cfDNA technology has been used in 2 articles published in Nature Medicine, 1 in Nature Communications, 1 in Science Translational Medicine, 1 in PNAS, and over 50 scientific articles in different journals.